The trajectory of companies tied to the drug's past presents a complex investment scenario . While the initial boom generated substantial gains, generic alternatives have significantly diminished sales . https://sb-bookmarking.com/story21741342/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-opportunity